Tango Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Tango Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q2 2024.
  • Tango Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $41.4M, a 8.72% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $41.4M -$3.95M -8.72% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $42.1M -$4.14M -8.95% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $43.5M -$3.38M -7.21% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $44.4M -$3.34M -6.98% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $45.3M +$44.8M +8616% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $46.2M +$45.3M +5071% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $46.9M +$45.6M +3639% Dec 31, 2022 10-K 2024-03-18
Q3 2022 $47.8M +$41M +609% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $520K Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $894K Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $1.25M -$6.23M -83.2% Dec 31, 2021 10-K 2023-03-27
Q3 2021 $6.73M Sep 30, 2021 10-Q 2021-11-09
Q4 2020 $7.48M Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.